Selecta Biosciences' Series B Round

Selecta Biosciences raised a round of funding on February 06, 2009.

Selecta Biosciences is a biopharmaceutical company developing a new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic a…

Articles about Selecta Biosciences' Series B Round: